These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 33318242)

  • 1. Fast and furious: flecainide toxicity presenting as monomorphic ventricular tachycardia.
    Donthi N; Chandrabhatla T; Genovese L; deFilippi C
    BMJ Case Rep; 2020 Dec; 13(12):. PubMed ID: 33318242
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arrhythmogenic effect of flecainide toxicity.
    Courand PY; Sibellas F; Ranc S; Mullier A; Kirkorian G; Bonnefoy E
    Cardiol J; 2013; 20(2):203-5. PubMed ID: 23558880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flecainide cardiotoxicity precipitated by electrolyte imbalance. Caution with thiazide diuretics.
    Khavandi A; Walker PR
    Emerg Med J; 2007 May; 24(5):e26. PubMed ID: 17452686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic Agent Induced Ventricular Tachycardia.
    Agrawal Y; Kalavakunta JK; Gupta V
    Am J Ther; 2017; 24(4):e487. PubMed ID: 27574940
    [No Abstract]   [Full Text] [Related]  

  • 5. Wide QRS Tachycardia in a Man With a Medical History of Atrial Fibrillation.
    Bucklew EA; Reis SE; Kancharla K
    JAMA Intern Med; 2019 Apr; 179(4):567-569. PubMed ID: 30776049
    [No Abstract]   [Full Text] [Related]  

  • 6. The Case of Flecainide Toxicity: What to Look for and How to Treat.
    Newson JM; Santos CD; Walters BL; Todd BR
    J Emerg Med; 2020 Aug; 59(2):e43-e47. PubMed ID: 32536493
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockade.
    Padfield GJ; AlAhmari L; Lieve KV; AlAhmari T; Roston TM; Wilde AA; Krahn AD; Sanatani S
    Heart Rhythm; 2016 Feb; 13(2):609-13. PubMed ID: 26416620
    [No Abstract]   [Full Text] [Related]  

  • 8. A multicentre, randomized trial on the benefit/risk profile of amiodarone, flecainide and propafenone in patients with cardiac disease and complex ventricular arrhythmias. Antiarrhythmic Drug Evaluation Group (A.D.E.G.).
    Eur Heart J; 1992 Sep; 13(9):1251-8. PubMed ID: 1396837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Irregular Wide Complex Tachycardia.
    Watts TE; McElderry HT; Kay GN
    Circulation; 2017 Aug; 136(8):773-775. PubMed ID: 28827222
    [No Abstract]   [Full Text] [Related]  

  • 10. Flecainide and amiodarone: combined therapy for refractory tachyarrhythmias in infancy.
    Fenrich AL; Perry JC; Friedman RA
    J Am Coll Cardiol; 1995 Apr; 25(5):1195-8. PubMed ID: 7897134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Digitalis Promotes Ventricular Arrhythmias in Flecainide- and Ranolazine-Pretreated Hearts.
    Ellermann C; Wolfes J; Puckhaber D; Bögeholz N; Leitz P; Lange PS; Eckardt L; Frommeyer G
    Cardiovasc Toxicol; 2019 Jun; 19(3):237-243. PubMed ID: 30515668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flecainide therapy suppresses exercise-induced ventricular arrhythmias in patients with CASQ2-associated catecholaminergic polymorphic ventricular tachycardia.
    Khoury A; Marai I; Suleiman M; Blich M; Lorber A; Gepstein L; Boulos M
    Heart Rhythm; 2013 Nov; 10(11):1671-5. PubMed ID: 23954267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Wide complex tachycardia in dialysis patients is not always hyperkalemia.
    Hoang K; Pazderka P; Hakmeh W
    Am J Emerg Med; 2022 Feb; 52():267.e5-267.e7. PubMed ID: 34391584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An irregular, extremely broad QRS complex rhythm.
    Wilgenhof A; Michiels V; Cosyns B
    Am J Emerg Med; 2019 Oct; 37(10):1989.e1-1989.e3. PubMed ID: 31362853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incessant monomorphic ventricular tachycardia induced by the proarrhythmic effect of amiodarone.
    Makimoto H; Noda T; Kurita T; Nakajima I; Yokoyama T; Doi A; Yamada Y; Okamura H; Satomi K; Aiba T; Shimizu W; Suyama K; Aihara N; Kamakura S
    Intern Med; 2011; 50(21):2591-5. PubMed ID: 22041363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparative multicenter clinical study of flecainide and amiodarone in the treatment of ventricular arrhythmias associated with chronic Chagas cardiopathy].
    Rosenbaum M; Posse R; Sgammini H; Núñez Burgos J; Chiale PA; Pastori JD; González Zuelgaray J; Brunetto JF; Califano JE
    Arch Inst Cardiol Mex; 1987; 57(4):325-30. PubMed ID: 2445316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of flecainide on exercise-induced ventricular arrhythmias and recurrences in genotype-negative patients with catecholaminergic polymorphic ventricular tachycardia.
    Watanabe H; van der Werf C; Roses-Noguer F; Adler A; Sumitomo N; Veltmann C; Rosso R; Bhuiyan ZA; Bikker H; Kannankeril PJ; Horie M; Minamino T; Viskin S; Knollmann BC; Till J; Wilde AA
    Heart Rhythm; 2013 Apr; 10(4):542-7. PubMed ID: 23286974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ventricular tachycardia induced by abuse of ephedrine in a young healthy woman.
    Rakovec P; Kozak M; Sebestjen M
    Wien Klin Wochenschr; 2006 Sep; 118(17-18):558-61. PubMed ID: 17009070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder].
    Rienstra M; Wiesfeld AC; van Veldhuisen DJ; van Gelder IC
    Ned Tijdschr Geneeskd; 2006 May; 150(18):1027-31. PubMed ID: 16715868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Monomorphic ventricular tachycardia during the ajmaline test].
    Akpınar O; Kurt K; Kanadaşı M
    Turk Kardiyol Dern Ars; 2013 Sep; 41(6):537-40. PubMed ID: 24104982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.